Ex-FDA Head To Testify In GSK Flonase Antitrust Row

Law360, Philadelphia (November 1, 2012, 4:57 PM EDT) -- A Pennsylvania federal judge struck a blow to GlaxoSmithKline PLC on Thursday, ruling that plaintiffs in a class action accusing it of illegally blocking development of a generic Flonase could tap former U.S. Food and Drug Administration chief David Kessler as an expert witness.

U.S. District Judge Anita Brody rejected GSK’s motion to exclude Kessler’s testimony, ruling that his experience with the agency made qualified him to render an opinion on whether the pharmaceutical company, as the plaintiffs allege, filed baseless petitions with the FDA in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

AMERICAN SALES COMPANY, INC. v. SMITHKLINE BEECHAM CORPORATION


Case Number

2:08-cv-03149

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

ANITA B. BRODY

Date Filed

July 3, 2008


Case Title

IBEW - NECA LOCAL 505 HEALTH & WELFARE PLAN v. SMITHKLINE BEECHAM CORPORATION


Case Number

2:08-cv-03301

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

ANITA B. BRODY

Date Filed

July 14, 2008


Case Title

ROXANE LABORATORIES, INC. v. SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE


Case Number

2:09-cv-01638

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Judge

ANITA B. BRODY

Date Filed

April 17, 2009

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.